In addition, higher circulating levels of insulin could impact cancer risk by regulating levels of sex hormone synthesis and chronic inflammation which in turn increase the risk of obesity-related cancer [8, 10]. The gene discussed is PLXNA3; the disease is obesity due to melanocortin 4 receptor deficiency.